D-LL-37 (13-32)[I13G,G14I]

General Information


DRACP ID  DRACP04184

Peptide Name   D-LL-37 (13-32)[I13G,G14I]

Sequence  Gikefkrivqrikdflrnlv

Sequence Length  20

UniProt ID  P49913 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C2H-33NO-17

Absent amino acids  ACDEFHIKLMNPQRSTVWY

Common amino acids  G

Mass  7183

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  94

Hydrophobicity  -2

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34959645

Title  Structure and Activity of a Selective Antibiofilm Peptide SK-24 Derived from the NMR Structure of Human Cathelicidin LL-37

Doi Not available

Year  2021

Literature 2

Pubmed ID 32252021

Title  Engineered Human Cathelicidin Antimicrobial Peptides Inhibit Ebola Virus Infection

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  18233

DRACP is developed by Dr.Zheng's team.